Highlights

  • OSCR’s Q1FY25 revenue rose by 42.2% YoY, driven by growth in premium revenue and higher investment income.
  • The company reported a 55.2% YoY increase in net income to USD 275.3 million for the period.
  • OSCR reaffirmed its FY2025 revenue guidance at USD 11.2–11.3 billion with an MLR of 80.7–81.7%.

Oscar Health, Inc. (NYSE: OSCR) is a health insurance company offering individual, family, and small group plans, and licensing its full-stack technology platform, +Oscar, to providers and payors.

In the first quarter of the financial year 2025 (Q1FY25), the company’s revenue rose by 42.2% YoY to USD 3,046.3 million, driven by growth in premium revenue and higher investment income. Net income available to common shareholders increased by 55.2% YoY to USD 275.3 million, supported by higher revenues, partially offset by increased total costs and expenses. As a result, net operating cash flow rose by 38.5% YoY, and total cash and cash equivalents grew by 46.4% YoY to USD 2,236.6 million, up from USD 1,527.2 million in Q1FY24.

Recent Business Update

Oscar Health disclosed that the Anahata Foundation, founded by CEO Mark T. Bertolini acquired 933,333 shares of the company on the open market during the week of November 11, 2024, with the disclosure made on November 18, 2024. While Oscar itself was not involved in the transaction, Bertolini expressed confidence in the company's talent, products, and technology as drivers of future growth and its role in reshaping the individual healthcare market.

Company Outlook

Oscar Health reaffirmed its FY2025 guidance, projecting revenue between USD 11.2 billion and USD 11.3 billion, with a medical loss ratio (MLR) ranging from 80.7% to 81.7%. The company also expects an SG&A expense ratio between 17.6% and 18.1%.

It forecasted operating earnings between USD 225 million and USD 275 million, and adjusted EBITDA approximately USD 140 million higher. Management remains confident in margin expansion and profitability, despite the expected end of monthly special enrollment periods.

Top 10 Shareholders

The top 10 shareholders of OSCR collectively hold approximately ~45.73% of the company’s shares, indicating a concentrated ownership structure. The largest stakes are held by The Vanguard Group, Inc. and BlackRock Institutional Trust Company, N.A., at 8.97% and 6.57%, respectively.

Stock Information

The stock has gained around 11.15% over the past three months and around 7.55% over the last six months. It is currently trading near the lower end of its 52-week range, between a high of USD 23.79 and a low of USD 11.20. As of June 16, 2025, the stock’s closing price stands at USD 14.95.

Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference data for all price data, currency, technical indicators, support, and resistance levels is June 16 2025. The reference data in this report has been partly sourced from EODHD/Others.

Technical Indicators Defined

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.